AFP Stimulates Glucose Metabolic Reprogramming Contributing to Hepatocellular Carcinoma Resist Sorafenib Through Activating PI3K/AKT Signalling Pathway.
- DOI
- 10.1111/jcmm.71226
- Published
- 2026 Jun
- Container
- Journal of cellular and molecular medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/jcmm.71226,
title = {AFP Stimulates Glucose Metabolic Reprogramming Contributing to Hepatocellular Carcinoma Resist Sorafenib Through Activating PI3K/AKT Signalling Pathway.},
author = {Zhou Y and Feng S and Chen Y and Lin B and Li W and Dong X and Liu K and Yin Q and Li M and Zhu M},
year = {2026},
journal = {Journal of cellular and molecular medicine},
doi = {10.1111/jcmm.71226},
url = {https://doi.org/10.1111/jcmm.71226}
}RIS
TY - JOUR TI - AFP Stimulates Glucose Metabolic Reprogramming Contributing to Hepatocellular Carcinoma Resist Sorafenib Through Activating PI3K/AKT Signalling Pathway. AU - Zhou Y AU - Feng S AU - Chen Y AU - Lin B AU - Li W AU - Dong X AU - Liu K AU - Yin Q AU - Li M AU - Zhu M PY - 2026 JO - Journal of cellular and molecular medicine DO - 10.1111/jcmm.71226 UR - https://doi.org/10.1111/jcmm.71226 ER -
APA
Y, Z., S, F., Y, C., B, L., W, L., X, D., K, L., Q, Y., M, L., & M, Z. (2026). AFP Stimulates Glucose Metabolic Reprogramming Contributing to Hepatocellular Carcinoma Resist Sorafenib Through Activating PI3K/AKT Signalling Pathway.. Journal of cellular and molecular medicine. https://doi.org/10.1111/jcmm.71226
Source records
- pubmed · retrieved 2026-09-25T10:24:22.552Z